Reference - Detail
| RRC ID | 43398 |
|---|---|
| Author | Yoshizaki T, Enomoto T, Fujita M, Ueda Y, Miyatake T, Fujiwara K, Miyake T, Kimura T, Yoshino K, Kimura T. |
| Title | Frequent inactivation of RUNX3 in endometrial carcinoma. |
| Journal | Gynecol Oncol |
| Abstract |
OBJECTIVE:Our objective was to determine whether RUNX3 tumor suppressor is inactivated in endometrial carcinoma. METHODS:We have investigated 24 endometrial carcinomas, 3 endometrial carcinoma cell lines, and 9 normal endometria for genetic and epigenetic alterations of RUNX3. Reverse-transcription PCR (RT-PCR), methylation-specific PCR (MS-PCR) analysis, and loss of heterozygosity (LOH) analysis were performed. We also tested RUNX3 protein expression by immunohistochemistry. RESULTS:Using RT-PCR technique, we observed a significant loss of RUNX3 mRNA expression in nine of 24 endometrial carcinomas (38%) and in all 3-cell lines (100%). In contrast, all nine of the normal endometria showed an abundant expression of RUNX3 mRNA. Methylation-specific PCR (MS-PCR) analysis of the CpG islands of RUNX3 showed the promoter region to be hypermethylated in 18 of 21 analyzed carcinomas (86%), whereas only two of nine normal endometria (22%) were methylated (p<0.01). By using two polymorphic microsatellite markers, D1S199 and D1S1676, we detected 1p36 LOH in 7 of 21 carcinomas (33%). We observed a significant relationship between the loss of RUNX3 mRNA expression and this regional LOH (p<0.01). Immunohistochemical staining showed that RUNX3 protein expression was lost in 12 of 21 endometrial carcinomas (57%). We observed a significantly more frequent loss of RUNX3 protein expression in the histologically higher-grade tumors (Grade 3) than in Grade 1 or 2 tumors (p<0.01). CONCLUSION:These findings indicate that RUNX3 inactivation may play an important role in carcinogenesis of the endometrium, especially in high-grade endometrial carcinoma. |
| Volume | 110(3) |
| Pages | 439-44 |
| Published | 2008-9-1 |
| DOI | 10.1016/j.ygyno.2008.05.004 |
| PII | S0090-8258(08)00358-2 |
| PMID | 18572225 |
| MeSH | Cell Line, Tumor Core Binding Factor Alpha 3 Subunit / biosynthesis Core Binding Factor Alpha 3 Subunit / genetics* DNA Methylation Endometrial Neoplasms / genetics* Endometrial Neoplasms / metabolism Endometrial Neoplasms / pathology Female Gene Expression Regulation, Neoplastic Gene Silencing Genes, Tumor Suppressor Humans Immunohistochemistry Loss of Heterozygosity RNA, Messenger / biosynthesis RNA, Messenger / genetics Reverse Transcriptase Polymerase Chain Reaction |
| IF | 4.623 |
| Times Cited | 13 |
| WOS Category | OBSTETRICS & GYNECOLOGY ONCOLOGY |
| Resource | |
| Human and Animal Cells | HHUA(RCB0658) |